SION

Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc. (SION) has 13 SEC Form 4 filings (62 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 9, 2026.

The most active filer is Insider Booth Bruce with 8 filings. Insiders have net sold $45.4M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Michael Cloonan
  • Employees:41
  • HQ:Waltham, MA, US
  • IPO:2025-02-07

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$67.3M

reported sales (SEC code S)

Unique Insiders

5

in the rolling window

Market Cap

$2.0B

latest known value

Source
Sale$3.9MJul 9SEC ↗
Sale$3.9MJul 9SEC ↗
Sale$447KJul 7SEC ↗
Sale$5.3MJul 2SEC ↗
Sale$5.3MJul 2SEC ↗
Sale$4KMay 30SEC ↗
Sale$4KMay 30SEC ↗
Thompson Peter A.First filing
Sale$2.2MMay 11SEC ↗
Thompson Peter A.First filing
Sale$2.7MMay 11SEC ↗
Thompson Peter A.First filing
Sale$8.5MMay 11SEC ↗
Sale$2.2MMay 11SEC ↗
Sale$2.7MMay 11SEC ↗
Sale$8.5MMay 11SEC ↗
Cloonan MichaelFirst filing
Sale$3.6MOct 22SEC ↗
Sale$3.0MOct 21SEC ↗
Sale$5.5MOct 20SEC ↗
Sale$2.0MOct 20SEC ↗
Sale$1.8MOct 20SEC ↗
Booth BruceFirst filing
Sale$607KOct 15SEC ↗
Booth BruceFirst filing
Sale$1.8MOct 15SEC ↗
Booth BruceFirst filing
Sale$18KOct 15SEC ↗
Booth BruceFirst filing
Sale$3.5MOct 15SEC ↗

Related companies

Sionna Therapeutics, Inc. is in the Healthcare sector.